P2.09. Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC) - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Jamie Feng
Meta Tag
Speaker Jamie Feng
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
TP53 variants
HER2-mutated non-small cell lung cancer
treatment outcomes
overall response rate
progression-free survival
TP53/HER2 co-mutations
targeted treatments
prognosis prediction
brain metastases
Powered By